V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007745 | 250005381 | 1.68 | 54 | Curative (C) | 2015-11-02 | 2015-11-08 | GemCarbo Days 1+8 | N | N | 250032876 | CARBOPLATIN + ETOPOSIDE |
| 250007746 | 250005382 | 1.64 | 89 | Palliative (P) | 2013-04-08 | 2013-04-09 | Pemetrexed | 02 | null | 250032878 | TRIAL |
| 250007747 | 250005383 | 1.79 | 103.2 | Disease modification (D) | 2013-12-07 | 2013-12-22 | IPM | Y | N | 250032879 | CISPLATIN + PACLITAXEL |
| 250007748 | 250009821 | null | null | Curative (C) | 2017-07-08 | 2017-07-15 | Pemetrexed | N | N | 250032880 | TRIAL |
| 250007749 | 250005384 | 1.74 | 0 | Curative (C) | null | 2015-11-17 | IPM | N | N | 250032890 | AZACITIDINE |
| 250007750 | 250005385 | 1.67 | 92.4 | Neo-adjuvant (N) | 2016-10-26 | 2016-10-31 | Pemetrexed | N | N | 250032891 | PEMETREXED |
| 250007751 | 250005385 | 1.54 | null | Palliative (P) | 2014-01-05 | 2014-01-14 | Oxaliplatin + Modified de Gramont | N | N | 250032891 | RUXOLITINIB |
| 250007752 | 250005386 | null | null | Neo-adjuvant (N) | 2016-04-09 | 2016-04-09 | Pemetrexed | 02 | N | 250032895 | PEMETREXED |
| 250007753 | 250005387 | null | 80.8 | Palliative (P) | 2017-05-30 | 2017-05-30 | Enzalutamide | 02 | N | 250032896 | VINORELBINE |
| 250007754 | 250005388 | null | null | Palliative (P) | 2017-03-23 | 2017-03-24 | DA 3 + 10 | 01 | null | 250032898 | GEMCARBO |
| 250007755 | 250005388 | 0 | 57.4 | Curative (C) | 2013-06-15 | 2013-06-15 | GEMCITABINE | 2 | N | 250032898 | EOX |
| 250007756 | 250005389 | null | 60.95 | Palliative (P) | 2014-05-15 | 2014-06-11 | HSV1716 | null | N | 250032913 | PEMETREXED |
| 250007757 | 250005389 | 1.76 | 61.2 | Curative (C) | 2015-02-04 | 2015-02-04 | Pemetrexed | 2 | N | 250032913 | CHLORAMBUCIL |
| 250007758 | 250005390 | 1.76 | 0 | Palliative (P) | 2018-01-25 | 2018-01-28 | Pemetrexed | N | N | 250032916 | CHOP R |
| 250007759 | 250005390 | 1.48 | 70 | Palliative (P) | null | 2013-11-18 | Carboplatin + Paclitaxel (3 weekly) | N | N | 250032916 | CISPLATIN + GEMCITABINE |
| 250007760 | 250005391 | 1.62 | 67.1 | Palliative (P) | 2018-12-28 | 2019-02-12 | Carboplatin + Etoposide IV 3 day | N | N | 250032923 | BORTEZOMIB |
| 250007761 | 250005392 | 1.75 | 79.9 | Disease modification (D) | 2014-07-27 | 2014-07-28 | Pemetrexed | Y | N | 250032924 | PEMETREXED |
| 250007763 | 250005394 | 1.7 | 98.9 | Curative (C) | 2015-09-17 | 2015-09-17 | Bortezomib +/- Dexamethasone | 02 | N | 250032926 | TRIAL |
| 250007765 | 250005396 | null | 59.7 | Palliative (P) | null | 2015-07-22 | Trial Unspecified | N | N | 250032936 | TRIAL |
| 250007766 | 250005397 | null | 87 | null | 2013-07-22 | 2013-08-22 | RUXOLITINIB | N | N | 250032938 | DOCETAXEL |
| 250007767 | 250005398 | 1.59 | null | Palliative (P) | 2016-05-15 | 2016-05-19 | CISPLATIN + Ganetespib + Ganetespib + PEMETREXED | 02 | null | 250032939 | BORTEZOMIB |
| 250007768 | 250005398 | 1.66 | 77 | Curative (C) | null | 2013-10-29 | PEMBROLIZUMAB | N | N | 250032939 | TRIAL |
| 250007769 | 250005399 | 1.7 | 0 | Curative (C) | 2013-02-14 | 2013-02-14 | Pemetrexed | Y | N | 250032945 | IPM |
| 250007770 | 250009827 | null | 95.4 | Disease modification (D) | 2013-12-01 | 2013-12-01 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 250032948 | PEMETREXED |
| 250007771 | 250005400 | 0 | 71 | Disease modification (D) | null | 2013-12-22 | Trial Unspecified | N | N | 250032950 | CYTARABINE |
| 250007772 | 250005401 | null | 0 | Not known (9) | 2015-12-01 | 2015-12-15 | AML 18 TRIAL | 02 | N | 250032952 | DABRAFENIB |
| 250007773 | 250005402 | null | null | Neo-adjuvant (N) | 2016-02-12 | 2016-02-22 | GEMCARBO | N | N | 250032960 | AZACITIDINE |
| 250007774 | 250005403 | 1.5 | 81.8 | Disease modification (D) | 2018-08-05 | 2018-08-10 | FIGARO TRIAL | N | N | 250032961 | GEMCARBO |
| 250007775 | 250009828 | 1.55 | 0 | Disease modification (D) | 2015-01-19 | 2015-02-03 | Trial Unspecified | N | N | 250032962 | CHOP R |
| 250007776 | 250005404 | 1.72 | 0 | Palliative (P) | 2017-05-03 | 2017-05-24 | AFATINIB | 2 | 2 | 250032966 | FEC |
| 250007777 | 250009829 | 1.5 | null | Disease modification (D) | 2014-09-11 | 2014-09-11 | Trial Unspecified | 02 | N | 250032967 | AZACITIDINE |
| 250007778 | 250005405 | 0 | null | Palliative (P) | 2016-12-26 | 2016-12-26 | Trial Unspecified | Y | N | 250032969 | IPM |
| 250007780 | 250009830 | 1.71 | 95.9 | Curative (C) | 2018-08-27 | 2018-08-27 | Trial Unspecified | N | N | 250032971 | CYTARABINE |
| 250007781 | 250005407 | 1.54 | 79.8 | Palliative (P) | 2017-04-03 | 2017-04-06 | CARBOPLATIN + GEMCITABINE | N | N | 250032977 | CISPLATIN + GEMCITABINE |
| 250007782 | 250005407 | 1.71 | 0 | Palliative (P) | 2016-07-22 | 2016-07-25 | Pemetrexed | 02 | N | 250032977 | PEMETREXED |
| 250007783 | 250005408 | null | 72 | Palliative (P) | 2017-07-01 | 2017-07-01 | SCOT TRIAL | N | N | 250032981 | CARBOPLATIN + ETOPOSIDE |
| 250007784 | 250005409 | null | null | Curative (C) | 2017-01-23 | 2017-01-23 | Vinorelbine IV | 02 | N | 250032989 | TRIAL |
| 250007785 | 250005410 | 1.85 | 0 | Disease modification (D) | null | 2013-10-11 | Pemetrexed | N | N | 250032992 | CARBOPLATIN |
| 250007786 | 250005410 | 1.67 | null | Adjuvant (A) | 2014-03-01 | 2014-03-07 | IPM | 1 | N | 250032992 | PEMETREXED |
| 250007788 | 250005412 | 1.87 | 0 | Disease modification (D) | 2014-04-14 | 2014-04-23 | Sorafenib | 2 | N | 250032999 | EOX |
| 250007789 | 250005413 | 1.7 | 84 | Not known (9) | 2013-08-28 | 2013-09-04 | Rituximab | N | null | 250033005 | TRIAL |
| 250007790 | 250005414 | 1.65 | 82.6 | Disease modification (D) | 2014-03-15 | 2014-03-26 | RUXOLITINIB | N | N | 250033007 | CARBOPLATIN |
| 250007791 | 250005414 | 1.61 | 63.4 | Disease modification (D) | 2017-02-05 | 2017-02-25 | Pemetrexed | Y | N | 250033007 | DABRAFENIB |
| 250007792 | 250005415 | 1.67 | null | Disease modification (D) | 2017-12-29 | 2017-12-29 | DA 3 + 10 | null | N | 250033011 | DABRAFENIB |
| 250007793 | 250005416 | null | null | null | 2017-12-18 | 2017-12-18 | Trial Unspecified | 02 | null | 250033012 | ANAGRELIDE |
| 250007796 | 250005419 | 1.69 | 72.3 | Curative (C) | 2016-08-02 | 2016-08-02 | Trial Unspecified | N | N | 250033020 | EOX |
| 250007799 | 250005421 | 1.55 | 67.2 | Disease modification (D) | null | 2015-06-02 | AML 18 TRIAL | N | N | 250033023 | CARBOPLATIN |
| 250007800 | 250009835 | null | 66 | Palliative (P) | 2013-05-08 | 2013-05-08 | Trial Unspecified | N | N | 250033028 | VINORELBINE |
| 250007801 | 250005422 | 1.6 | null | Palliative (P) | null | 2014-05-05 | Carboplatin + Etoposide IV 3 day | 1 | N | 250033031 | BORTEZOMIB |
| 250007802 | 250005422 | 0 | 88.4 | Disease modification (D) | 2013-06-24 | 2013-06-30 | RUXOLITINIB | N | N | 250033031 | CHOP R |